Search
for
Sort by
Research 361–390 of 1000+
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Malnutrition and Allergies: Tipping the Immune Balance towards Health
- An Update on Drug-Induced Pigmentation
- The use of complementary and alternative medicine among dermatology outpatients in Eastern Turkey
- FOX FORDYCE DISEASE IN A PREPUBERTAL GIRL
- Toxic epidermal necrolysis due to cephalexin
- GEOGRAPHIC TONGUE IN TWO CHILDREN WITH NONPUSTULAR PSORIASIS
- CUTANEOUS MASTOCYTOSIS IN CHILDREN: AN INDIAN EXPERIENCE
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Thyroxin Levels and Haematological changes in Dogs with Sarcoptic Mange
- Feline paraneoplastic alopecia associated with metastasising intestinal carcinoma
- A systematic review of randomized controlled trials assessing phytochemicals and natural ingredients for skin and hair care
- Exuberant tufted folliculitis
- Annual Convention in the Time of COVID
- STEROID HORMONES IN GERIATRICS
- Non-scarring Alopecia in Pemphigus Foliaceus
- Rightly Said Hair Heat Disease!
- Dermatological considerations for transgender and gender diverse patients: An Australian perspective
- Erythema multiforme in a Central American tapir (Tapirus bairdii) calf, clinical case report
- Toxic and Metabolic Disorders of the Nervous System
- Post-steroid panniculitis: a lost and forgotten entity?
- Scalp Arteriovenous Fistula following Hair Transplantation: A Case Report and Review of the Literature
- Dermatologists’ Role in Interdisciplinary Care for Obsessive-Compulsive Disorder and Body-Focused Repetitive Behaviors
- Psychocutaneous disease
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- What causes hidradenitis suppurativa ?—15 years after
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Hair and scalp disorders in ethnic populations
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Acquired scalp alopecia. Part I: A review